Weight-loss jab Wegovy sees another prescription boost after ban on copycats
Novo CEO ousted in May, in place until successor named
The Independent UK ·
Get all your news in one place.
100's of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100's of premium titles. One news app.
The Latest Breaking News from Lars Fruergaard Jorgensen
Breaking Down Thursday’s Top 3 Unusually Active Options
In Thursday’s unusual options activity, there were 1,399, split almost evenly between puts (705) and calls (694). Of the top 100 by Vol/OI ratios, the top three ratios range from 81.86 to 69.31.
Barchart ·
Ozempic-maker Novo Nordisk Says CEO To Step Down
Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said Friday its chief executive was stepping down in the wake of "market challenges".
International Business Times ·
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Coverage From
Fortune
Barchart
Benzinga
International Business Times
The Independent UK
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Organisations
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Topics
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
100+ trusted global sources.
